MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Viatris P/B Ratio 2011-2026 | VTRS
Annual P/B Ratio Viatris
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 0.898 | 0.646 | 0.649 | 0.386 | 0.951 | 1.3 | 1.77 | 1.68 | 2.55 | 6.06 | 5.9 | 3.49 | 2.58 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.06 | 0.386 | 2.22 |
P/B Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.0724 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
3.46 | $ 5.69 | -0.52 % | $ 84.5 M | USA |
 |
HEXO Corp.
HEXO
|
0.88 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
0.687 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
0.644 | $ 2.77 | -0.72 % | $ 1.06 B | Canada |
 |
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
37.1 | $ 36.71 | 9.7 % | $ 1.35 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
9.71 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.777 | $ 2.54 | 2.22 % | $ 322 M | USA |
 |
Canopy Growth Corporation
CGC
|
0.291 | $ 1.03 | 0.98 % | $ 111 M | Canada |
 |
Pacira BioSciences
PCRX
|
1.51 | $ 23.73 | 2.24 % | $ 1.1 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
0.83 | $ 1.09 | -1.8 % | $ 1.35 M | USA |
 |
Solid Biosciences
SLDB
|
3.46 | $ 6.56 | -0.15 % | $ 574 M | USA |
 |
Aurora Cannabis
ACB
|
0.368 | $ 3.35 | -0.88 % | $ 184 M | Canada |
 |
Jupiter Wellness
JUPW
|
-1.09 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-1.43 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
0.492 | $ 1.09 | 0.46 % | $ 104 M | Canada |
 |
Tilray
TLRY
|
0.358 | $ 5.18 | 0.1 % | $ 3.2 B | Canada |
 |
Evolus
EOLS
|
-11.7 | $ 6.77 | 1.04 % | $ 436 M | USA |
 |
Sundial Growers
SNDL
|
0.000669 | $ 1.46 | - | $ 3.37 M | Canada |
 |
cbdMD
YCBD
|
0.495 | $ 0.7 | -2.1 % | $ 2.82 M | USA |
 |
Emergent BioSolutions
EBS
|
0.865 | $ 8.15 | 2.52 % | $ 436 M | USA |
 |
Veru
VERU
|
4.63 | $ 3.11 | 0.32 % | $ 45.5 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
0.802 | $ 23.49 | 0.11 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
2.05 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.56 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
5.38 | $ 5.3 | 2.42 % | $ 1.97 B | Canada |
 |
PetIQ
PETQ
|
0.456 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
2.85 | $ 6.36 | 1.36 % | $ 251 M | USA |
 |
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-0.148 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
0.769 | $ 4.25 | -2.52 % | $ 212 M | USA |
 |
PLx Pharma
PLXP
|
2.31 | - | -27.8 % | $ 2.56 M | USA |
 |
Zomedica Corp.
ZOM
|
0.572 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.406 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
0.914 | $ 0.66 | -4.28 % | $ 23.7 M | USA |
 |
Tricida
TCDA
|
1.87 K | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
0.121 | $ 0.76 | 5.54 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
0.857 | $ 1.88 | - | $ 21.7 M | USA |